VANCOUVER, BC, CANADA (June 10th, 2020) – Codebase Ventures Inc. ("Codebase" or the "Company") (CSE: CODE - FSE: C5B – OTCQB: BKLLF) an investment company, is providing an update on its investment in World High Life Plc (AQSE: LIFE) (OTCQB: WRHLF).
World High Life’s wholly owned subsidiary, Love Hemp Ltd (Love Hemp), has announced that it has appointed Dr. Sepe Sehati as Chief Scientific and Regulatory Advisor. Dr. Sehati is a renowned healthcare innovator and a Fellow of the Royal Society of Medicine. A passionate advocate and practitioner of both critical thinking and tactical cross-pollination of disciplines, Sepe holds a Doctorate in Bioengineering from the University of Oxford.
Sepe’s innovative approach to problem solving fuelled through the application of diverse scientific fields, analytics, neuroscience, behavioural science and evidence-based principles has led him to contribute to various high-profile initiatives ranging from President Obama’s Transition Health Policy, to the UK Prime Minister’s sustainable development plan, to the late Dr Richard Rockefeller’s innovative healthcare models. Sepe is also an advisor for the Centre for Medicinal Cannabis.
Highlights of Dr. Sehati Appointment as Love Hemp Chief Scientific & Regulatory Advisor
- Sehati holds a Doctorate in Bioengineering from the University of Oxford
- Fellow of the Royal Society of Medicine
- Contributor to President Obama’s Transition Health Policy
- Contributor to the UK Prime Minister’s sustainable development plan
- Advisor for the Centre for Medicinal Cannabis
Love Hemp Founder and CEO, Tony Calamita notes that Dr. Sehati’s experience will be a tremendous asset as CBD continues to gain momentum with consumers, playing an instrumental role as Love Hemp continues to expand its range of trusted CBD products.
